It is a healthcare private limited company based in East Delhi, Delhi, India, established in 2009.
2009 | East Delhi, Delhi, India | ActiveMedifuture Pharmaceuticals Private Limited, a active private limited company, was established on 02 June 2009 in East Delhi, Delhi, India. Engaging in ayurvedic products & services within the trade sector, it holds CIN: U36103DL2009PTC190810. Registered under ROC Roc Delhi. it is unlisted. It has an authorized capital of ₹5.00 M and a paid-up capital of ₹1.50 M.
It upholds a compliant status. Its leadership includes Shashi Setia (Director), Aastha Setia (Director). Past directors included Aarati Bisht, Mahasweta Sahoo, Shashi Setia. Its latest AGM occurred on 23 September 2025, with the balance sheet filed on 31 March 2025. It is based at Unit No. 206, Tower-A, Nextra The Address,, Plot No. 4B, District Centre, Mayur Vihar Phase-1 Extension, East Delhi, Delhi, 110091.
U36103DL2009PTC190810
190810
02 June 2009
₹5.00 M
₹1.50 M
Roc Delhi
Unlisted
Active
Explore comprehensive insights into Medifuture Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Shashi Setia | Director | 16 Aug 2018 | Current |
| Aastha Setia | Director | 25 Oct 2021 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Additional Director | 30 Sep 2018 | Past |
| Pramod Abcsdd | Additional Director | 31 Dec 2020 | Past |
| Pramod Abcsdd | Additional Director | 30 Sep 2018 | Past |
| Pramod Abcsdd | Director | 29 Oct 2020 | Past |
| Pramod Abcsdd | Director | 29 Oct 2017 | Past |
| Pramod Abcsdd | Director | 20 Mar 2014 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Medifuture Pharmaceuticals Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 5542.61% increase. The company also saw a slight decrease in profitability, with a 0.9% decrease in profit. The company's net worth Soared by an impressive increase of 28.54%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
Unlock access to Medifuture Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Unlock and access historical data on people associated with Medifuture Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Medifuture Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Medifuture Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
The activity Medifuture Pharmaceuticals Private Limited last Annual general meeting of members was held on 23 Sep 2025 as per latest MCA records. was completed.
Progress on Medifuture Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Delhi. was documented.
Aastha Setia was appointed as a Director was appointed as a Director on 25 Oct 2021 & has been associated with this company since 4 years 1 month . was recorded as a recent event.
Progress on Shashi Setia was appointed as a Director was appointed as a Director on 16 Aug 2018 & has been associated with this company since 7 years 3 months . was documented.
The activity Medifuture Pharmaceuticals Private Limited was registered on 02 Jun 2009 with Roc Delhi & aged 16 years 5 months as per MCA records. was completed.
The CIN of Medifuture Pharmaceuticals Private Limited is U36103DL2009PTC190810.
Medifuture Pharmaceuticals Private Limited is headquartered at Unit No. 206, Tower-A, Nextra The Address,, Plot No. 4B, District Centre, Mayur Vihar Phase-1 Extension, East Delhi, Delhi, 110091.
Medifuture Pharmaceuticals Private Limited was incorporated on 02 June 2009.
The current directors of Medifuture Pharmaceuticals Private Limited are
The primary industry of Medifuture Pharmaceuticals Private Limited is Trade.
Medifuture Pharmaceuticals Private Limited is unlisted.
The authorized capital of Medifuture Pharmaceuticals Private Limited is ₹5.00 M, and the paid-up capital is ₹1.50 M.
The compliance status of Medifuture Pharmaceuticals Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX